KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.58 $2.30 Friday, 26th Apr 2024 CTMX stock ended at $1.59. This is 0.625% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.77% from a day low at $1.59 to a day high of $1.65.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Apr 28, 2023 $1.58 $1.66 $1.56 $1.63 296 332
Apr 27, 2023 $1.58 $1.59 $1.54 $1.59 292 426
Apr 26, 2023 $1.59 $1.60 $1.53 $1.57 459 268
Apr 25, 2023 $1.62 $1.65 $1.59 $1.61 408 225
Apr 24, 2023 $1.65 $1.66 $1.61 $1.63 462 511
Apr 21, 2023 $1.64 $1.69 $1.62 $1.65 212 884
Apr 20, 2023 $1.66 $1.71 $1.63 $1.63 426 292
Apr 19, 2023 $1.65 $1.70 $1.62 $1.70 285 945
Apr 18, 2023 $1.72 $1.72 $1.63 $1.65 441 375
Apr 17, 2023 $1.66 $1.73 $1.66 $1.71 559 524
Apr 14, 2023 $1.70 $1.72 $1.64 $1.66 373 012
Apr 13, 2023 $1.63 $1.76 $1.61 $1.73 707 653
Apr 12, 2023 $1.71 $1.73 $1.62 $1.63 537 564
Apr 11, 2023 $1.60 $1.70 $1.56 $1.68 746 813
Apr 10, 2023 $1.53 $1.61 $1.52 $1.60 810 388
Apr 06, 2023 $1.49 $1.57 $1.48 $1.56 406 999
Apr 05, 2023 $1.50 $1.53 $1.46 $1.49 568 605
Apr 04, 2023 $1.54 $1.57 $1.49 $1.49 454 170
Apr 03, 2023 $1.53 $1.57 $1.51 $1.54 506 475
Mar 31, 2023 $1.46 $1.53 $1.46 $1.51 798 658
Mar 30, 2023 $1.52 $1.55 $1.44 $1.48 1 196 007
Mar 29, 2023 $1.54 $1.58 $1.46 $1.54 1 238 150
Mar 28, 2023 $1.48 $1.63 $1.43 $1.52 3 740 527
Mar 27, 2023 $1.75 $1.84 $1.74 $1.79 1 356 645
Mar 24, 2023 $1.70 $1.73 $1.65 $1.70 904 495
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT